Vaccine acceptance: Science, policy, and practice in a 'post-fact' world.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
29 01 2019
Historique:
received: 29 03 2018
revised: 04 09 2018
accepted: 10 12 2018
pubmed: 9 1 2019
medline: 26 2 2020
entrez: 9 1 2019
Statut: ppublish

Résumé

Suboptimal vaccination uptake may be associated with outbreaks of vaccine-preventable diseases in many parts of the world. Researchers and practitioners working on improving vaccine acceptance and uptake gathered together for the fifth annual meeting on vaccine acceptance, organized by the Fondation Mérieux at its conference centre in Veyrier-du-Lac, France, to share their experiences in building, improving and sustaining vaccine confidence and uptake. The importance and value of truly listening to people and seeking to understand the perspectives of vaccine hesitant people was emphasized throughout the meeting. The benefits of social marketing, which can be used to influence behavior that benefit individuals and communities for the greater social good, and its integration into strategies aimed at improving vaccine acceptance and uptake, were discussed. Healthcare professionals (HCPs) need tools and training to help them engage effectively in vaccination acceptance conversations with parents and other patients. Two potential tools, motivational interviewing (MI) and AIMS (Announce, Inquire, Mirror, Secure), were presented. Examples of MI approaches that have successfully improved vaccination acceptance and uptake included a project in Canada aimed at parents just after the birth of their baby. The role of mandates to increase vaccination uptake in the short-term was discussed, but to achieve sustainable vaccination uptake this must be complemented with other strategies. These annual meetings have led to the creation of an informal community of practice that facilitates cross-pollination between the various disciplines and different settings of those involved in this area of research and implementation. It was agreed that we must continue our efforts to promote vaccine acceptance and thus increase vaccination uptake, by fostering more effective vaccination communication, monitoring of the media conversation on vaccination, designing and rigorously evaluating targeted interventions, and surveillance of vaccine acceptance and uptake with pertinent, reliable measures.

Identifiants

pubmed: 30616955
pii: S0264-410X(18)31674-8
doi: 10.1016/j.vaccine.2018.12.014
pii:
doi:

Substances chimiques

Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

677-682

Informations de copyright

Copyright © 2018.

Auteurs

Katie Attwell (K)

School of Social Science, University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Australia. Electronic address: katie.attwell@uwa.edu.au.

Eve Dube (E)

Centre de recherche du CHU de Québec, Université Laval, Institut national de santé publique du Québec, 2400 D'Estimauville, Québec, QC G1E 7G9, Canada. Electronic address: eve.dube@inspq.qc.ca.

Arnaud Gagneur (A)

Department of Pediatrics, Faculty of Medicine and Health Sciences, Université de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada. Electronic address: Arnaud.Gagneur@USherbrooke.ca.

Saad B Omer (SB)

Hubert Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA, USA. Electronic address: somer@emory.edu.

L Suzanne Suggs (LS)

BeCHANGE Research Group, Institute of Public Communication, Faculty of Communication Sciences, Università della Svizzera italiana, via G. Buffi 13, Lugano, Switzerland; Swiss School of Public Health (SSPH+), Zurich, Switzerland; Institute for Global Health Innovation, Imperial College London, United Kingdom. Electronic address: Suzanne.suggs@usi.ch.

Angus Thomson (A)

Sanofi Pasteur, 14 Espace Henry Vallee, 69007 Lyon, France. Electronic address: Angus.Thomson@sanofi.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH